retatrutide clinical trial results 2024 Lilly's triple agonist achieves 16.8% weight loss in phase 3 eli lilly retatrutide press release

Major Risks of Compounded Semaglutide Using compounded semaglutide has some potential risks that you need to talk about with your doctor

doi: 10.1073/pnas.2014879117 233 ChoeHJChoYM

Properly stored at refrigerated temperatures and shielded from light, a reconstituted vial generally maintains stability for roughly 24 weeks before degradation becomes a concern, while the unmixed, lyophilized powder can remain stable for months when kept frozen and undisturbed

Compounded Retatrutide: A Specific Risk Layer Because retatrutide is not FDA-approved, the only current non-trial access point is compounding pharmacies, which operate under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act

Memory is unreliable, especially when you are managing multiple vials or running multi-month protocols